1. Home
  2. COSM vs RNAZ Comparison

COSM vs RNAZ Comparison

Compare COSM & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cosmos Health Inc.

COSM

Cosmos Health Inc.

N/A

Current Price

$0.30

Market Cap

33.8M

Sector

Health Care

ML Signal

N/A

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

N/A

Current Price

$1.64

Market Cap

27.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COSM
RNAZ
Founded
2009
2016
Country
Greece
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.8M
27.9M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
COSM
RNAZ
Price
$0.30
$1.64
Analyst Decision
Analyst Count
0
0
Target Price
★ $2.95
N/A
AVG Volume (30 Days)
★ 2.4M
29.5K
Earning Date
11-16-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 46.15
N/A
EPS
★ N/A
N/A
Revenue
★ $65,271,815.00
N/A
Revenue This Year
$30.85
N/A
Revenue Next Year
$51.74
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 19.93
N/A
52 Week Low
$0.16
$1.52
52 Week High
$0.83
$12.60

Technical Indicators

Market Signals
Indicator
COSM
RNAZ
Relative Strength Index (RSI) 50.09 42.81
Support Level $0.29 $1.57
Resistance Level $0.40 $1.95
Average True Range (ATR) 0.04 0.16
MACD -0.01 0.03
Stochastic Oscillator 46.31 21.95

Price Performance

Historical Comparison
COSM
RNAZ

About COSM Cosmos Health Inc.

Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: